Probably initially. I feel it's unlikely that they will sell off the IP rather than license it, which leads me to believe they will offer a lower initial price to let the purchaser run a Ph3.
Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials, page-289
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 5.2¢ | $160.0K | 3.048M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 882045 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 457736 | 5 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |